A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
Conditions: Metastatic Breast Cancer; Locally Advanced Breast Cancer; Breast Cancer Interventions: Drug: Samuraciclib; Drug: Elacestrant Dihydrochloride Sponsors: Carrick Therapeutics Limited; Berlin-Chemie AG Menarini Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials